Inside the secondary analysis, the significantly less conservative but clinically meaningful criterion of stable reaction (outlined to be a fifty% or more reduction in MADRS from baseline for two months) was used. Of your patients who reached stable response, twenty five.eight% inside the esketamine group and 57.6% in the placebo https://robertr900pft8.blog-gold.com/profile